Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
N8yqtJJRnq3Bz5wH
Listen
